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ABSTRACT 
This paper is an organization and conceptualization of a genetic account of human consciousness 
and to establish an initial list of the neurogenetic correlates of consciousness (NgCC).  This will 
be accomplished by establishing networks of genes that are involved in the multiple facets of the 
process of human consciousness.  The methodology utilized in this work is the evaluation of a 
small number of genes that have been researched experimentally in order to understand their role 
in brain development and function.  The results demonstrate that most neurogenetic genes can be 
categorized into three phases: the emergence of neuron-based consciousness, the continuum of 
neuron-based consciousness, and the neurodegeneration of consciousness.  This work also 
revealed that some genes have a function in more than one of the neurogenetic phases.  As of 
now a starting point has been established in terms of identifying some NgCC but there is room 
for expansion as there are likely to be hundreds of more genes that have yet to be identified or 
the function pertaining to human consciousness has not yet been fully understood.   
 
Introduction 
A framework of consciousness based on the neural correlates of consciousness (NCC) was 
proposed by Francis Crick and Christof Koch in 2003.1  Within this framework brain systems are 
active in tandem with the conscious experience.  Some of the NCC were discussed at the 
Towards a Science of Consciousness 2012 conference.  Here is a quick summary of some of the 
NCC currently being investigated: 
• Areas affected by anesthesia e.g. the frontal cortex integration to the posterior parietal 
cortex. 
• Decreases in brain connectivity and cerebral integration seen in PET scans and fMRI 
studies in patients in vegetative states (unresponsive wakefulness syndrome) and 
minimally conscious states. 
• Frontoparietal connections that provide a global workspace.  Two examples of these 
connections are: 1) lateral prefrontal and parietal cortices that function to provide external 
sensory awareness and 2) precuneal and mesiofrontal midline activity functions to 
provide an internal awareness. 
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• Critically emergent properties of collective widespread connectivity of consciousness 
found in the thalamo-cortical regions. 
For more detail on the Towards a Science of Consciousness 2012 conference a conference report 
is available.2  
The neurogenetic correlates of consciousness (NgCC) is a newer field of consciousness studies 
that focuses on the study of genes and gene products (e.g. transcription factors) that are involved 
in (and have an effect on) the conscious experience, or what I have termed the continuum of 
neuron-based consciousness.  Another way of saying this is that the NgCC are actively 
underlying the NCC during all points of the conscious experience.  In addition to the continuum 
of neuron-based consciousness, NgCC are also found in the initial construction of the brain and 
nervous system, as well as in the later in life processes of neurodegeneration.  These 
neurogenetic phases will be discussed section by section in this article. 
We must keep in mind that the genetic quality underlying the NCC works on a very different 
scale than the neurons themselves.  The neurons work at amazing speeds and utilize quantum 
properties, for example the movement of electrons across the synapse or along the length of an 
axon.   Another example of quantum properties utilized by neurons is the quantum mechanical 
electron tunneling effects that take place with in the synaptic cleft, which was described by Evan 
Harris Walker.3  
The proper functioning of the neurons underlies many of the modalities that integrate the 
conscious experience of the human brain.  This can be seen at the level of interactions between 
the brain and the environment.  For example, the optic nerve needs to function properly in order 
to see what is there, the amygdala needs to function in order to rate the appropriate response to 
what is seen, and the hippocampus needs to function properly in order to remember what was 
seen.  However, beneath the proper functioning of any of the neurons is the proper functioning of 
the genome.  There is also a network of RNA and protein species that are constantly interacting 
with each other and the genome.  Thus, as the neurons function on their scale of performance 
during a conscious experience the DNA, RNA, and proteins are functioning below that on a 
different scale.   
Similar to the neurons the DNA scale also utilizes quantum properties, but they are poorly 
understood at this point, for example the quantum nature of hydrogen bonding forces between 
the nucleotides, DNA methylation determination, and chromatin signals.  This network of 
nucleotides and proteins interacting at this particular scale of complexity has been referred to as 
DNA consciousness, which is a degree of consciousness that is different from the degree of 
human consciousness.4  Not only is DNA consciousness a degree of consciousness in it’s own 
right, but this degree of consciousness possesses the ability to give rise to higher degrees of 
consciousness e.g. cellular consciousness and human consciousness.  When the degree of DNA 
consciousness gives rise to human consciousness I propose that it occurs in three neurogenetic 
phases, which will be the topic of this paper.  Before I discuss the three neurogenetic phases I 
will first need to explain how they were developed.  Consequently it is necessary to explain three 
other concepts that precede the three neurogenetic phases of human consciousness. 
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Where did the concept of the three neurogenetic phases of human consciousness emerge? 
The three phases of the neurogenetics of consciousness were first presented, collectively, at the 
U.S. Psychiatric and Mental Health Congress Conference November 2011, in Las Vegas, 
Nevada- “The Neurogenetics of Consciousness”.5  However, I did also briefly mention the 
neurogenetics of consciousness at an earlier presentation at the Towards a Science of 
Consciousness Conference at Stockholm, Sweden, May 2011- “DNA Consciousness”.6  At that 
time the three phases were: 
• Neurogenesis- the focus was primarily on Hox and Pax genes that are involved in body 
patterning and the early emergence of the brain regions. 
•  Genetic mutations that affect degrees of human consciousness and are associated with 
psychiatric disorders. 
•  Genes involved in neurodegeneration- the focus was primarily on genes involved in 
Alzheimer disease (AD) as a primary example of a neurodegenerative process that affects 
modalities of human consciousness. 
Additionally, the neurogenetics of consciousness as a newer topic was discussed in detail in the 
chapter “DNA Consciousness: From Theory to Science” which is forthcoming in Ingrid 
Fredriksson’s Aspects of Consciousness II.7    Some of the contents of that chapter will be 
highlighted in this article as well during the discussion of the current description of these three 
neurogenetic phases. 
The main points regarding the neurogenetics of human consciousness and the direct relationship 
that it maintains with DNA consciousness was discussed further at a presentation at the Towards 
a Science of Consciousness Conference at Tucson, Arizona April 2012- “Neurogenetics and 
DNA Consciousness”.8  Next, more conclusive work was done on the third neurogenetic phase 
and these results were presented at the International Journal of Arts and Sciences Harvard 
Conference at Boston, Massachusetts May 2012- “Alzheimer’s Disease and DNA 
Consciousness”.  Finally, the three neurogenetic phases of human consciousness were presented 
at the Vigier VIII- British Computer Society Joint Meeting Conference at London, England 
August 2012- “The Neurogenetic Correlates of Consciousness”.  The proceedings from the 
Vigier conference are an initial outline of the three neurogenetic phases of human 
consciousness.9  Also in this particular work the importance of neuron plasticity to the second 
neurogenetic phase was recognized.    
In conclusion, the investigation of the three neurogenetic phases of human consciousness and 
their emergence as a topic span research done during the course of five conference presentations 
and the completion of a book chapter.  As a result of obtaining new information and revising the 
three neurogenetic phases of consciousness the titles were modified: 
• Phase One: The emergence of neuron-based consciousness 
• Phase Two: The continuum of  neuron-based consciousness 
• Phase Three: Neurodegeneration 
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 Making a connection: From genes to consciousness 
As mentioned previously, the NCC has been established as a minimal set of neuronal events that 
give rise to a specific aspect of a conscious percept.  So how then are genes also involved in a 
minimal set of neuronal events that gives rise to a specific aspect of a conscious percept?  I 
propose that the NgCC lie beneath and should be considered a substructure to any of the NCC.  
This theme will be addressed rigorously in the discussion of all three neurogenetic phases.    
However, before I discuss the three phases of the neurogenetics of human consciousness I must 
briefly provide a general definition of three other concepts: the interaction-based model of 
consciousness, the concept of interaction-complexity-consciousness (ICC), and the theory of 
DNA consciousness. 
The Interaction-based Model of Consciousness, ICC, and DNA Consciousness 
When approaching the three neurogenetic phases of consciousness a completely different 
approach in thinking is required.  This thinking requires a slightly different way of defining what 
consciousness is.  Therefore, I will very briefly define these three concepts in order to establish a 
general understanding so that we can move on to the main goal of this article which is discussing 
the three neurogenetic phases of consciousness.  The interaction-based model of consciousness, 
the ICC, and DNA consciousness have all been discussed in other works listed in the references, 
specifically the article The DNA molecule is autopoietic, dynamic, evolving, and a form of 
consciousness if the reader requires more detail.4 
The interaction-based model of consciousness defines consciousness as the interaction of things 
(be it an organism, DNA molecule, or atom) with other things, the external environment, 
different forms of energy, and forces.  This concept is built upon the foundation that 
consciousness is interaction.  This allows everything in the universe to have a degree of 
consciousness; from quarks to molecules to cells to brains- as they all interact in various degrees.  
This definition maintains that without interactions consciousness is glaciated. 
An interesting phenomenon occurs when following the recurring salient thematic element of the 
interaction-based model of consciousness and that is as things interact they become more 
complex.  So complexity appears to be bridging the gap and serving as an operator 
(mathematically) between interactions and degrees of consciousness i.e. how those degrees of 
consciousness are affected.  For example, if we take a handful of quarks there is a certain type of 
interaction taking place on a certain level of complexity which gives rise to a degree of 
consciousness- some may consider this quantum or primordial consciousness.  However, as 
these quarks continue to interact and form subatomic particles and those subatomic particles 
begin to form small molecules e.g. hydrogen and helium, there is now interactions on a different 
level.  As a result we have a different scale of complexity and a higher degree of consciousness- 
some may consider this atomistic consciousness.  At this point we can visualize the relationship 
of interactions and the ensuing concept of interaction-complexity-consciousness (ICC). 
The concept of the ICC states that as things interact they become more complex and as 
complexity increases there is an associated increase in the resulting degree of consciousness.  
Thus all matter and energy in the universe is seen to have a degree of consciousness that ascends 
in a complexity-dependent fashion via interactions.  In this way the ICC is an extension of the 
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interaction-based model of consciousness, with the notion of complexity being the bridge or 
operator connecting interactions and consciousness.  Please keep in mind that the ICC is not a 
rating system of consciousness, nor is it an attempt to establish a teleology placing humankind at 
the top.  It is recognition of how everything in the universe possesses a degree of consciousness. 
Now that we have a general understanding of the interaction-based model of consciousness and 
the ICC allow me to discuss another illustration.  I have made a demonstration involving quarks, 
subatomic particles, and atoms interacting and giving rise to complexity-dependent degrees of 
consciousness.  Thus the next step would be to discuss the molecular degree of consciousness.  
At this level molecules emerge and something special takes place- the assembly of nucleotides.  
This begins with RNA (ribonucleic acid) species and shortly thereafter DNA (deoxyribonucleic 
acid).  This is a special degree of consciousness known as DNA consciousness.  The interactions 
between RNA and DNA allow an explosion in complexity and a subsequent explosion in various 
degrees of consciousness.  Although I maintain that RNA in all likelihood appeared first it was 
not able to launch an explosion of consciousness anywhere close to the robustness of the 
explosion catalyzed by the emergence of DNA.  This is why I give priority to DNA in the theory 
or phrase DNA consciousness while still recognizing the importance of RNA. 
 
The theory of DNA consciousness maintains that DNA has a degree of consciousness (which is 
supported by the ICC) and that it possesses the ability to give rise to other degrees of 
consciousness.  For example, DNA consciousness provides the platform for cellular 
consciousness to emerge (also called polyzoism).  Cells continue to evolve and form tissues and 
multicellular organisms due to the development of new genes.  Eventually cells will develop new 
genes that allow the transformation of simple neurons to emerge.  An example of one of these 
types of genes is the synapsins genes. 
There are three mammalian synapsins genes (I, II, and III), although orthologs (versions of genes 
found in more than one species traced to a common ancestor) are found in the invertebrates and 
lower vertebrates.  Synapsins genes code for synapsins proteins.  It is well established that 
synapsins modulate neurotransmitters at the pre-synaptic terminal of the neuron.  Specifically, 
synapsins III has been demonstrated to negatively regulate the release of dopamine whereas 
serotonin appears to be unaffected.10  These genes also have been shown to play a critical role in 
neuronal development.11  More recently, synapsins have also been shown to not only be involved 
in dopamine release but in the fine-tuning of neuronal plasticity.12  Therefore it can be seen how 
a novel gene family that is being expressed can contribute to a neuron becoming a neuron.  Of 
course keep in mind that many other genes are responsible for the differentiation of a neuron. 
There are many genes that are known that produce transcriptional proteins and neurotrophic 
factors that are critical for the development of neurons.  The vast majority of these genes are not 
expressed in other cell types, thus a distinction is made from cellular consciousness and neuron-
based consciousness.  The genomic expression of certain genes allows a neuron to be a neuron; 
as seen in our example with the synapsins.  This is not a merely random act!  There is a degree of 
consciousness at work, which I have proposed to be DNA consciousness.   
At this point in the ICC we have the arrival of neurons and the emergence of nascent degrees of 
neuron-based consciousness.  This is seen in many of the higher invertebrates that have large 
nerves that allow them to interact with the environment in a completely new way.  As time goes 
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on these organisms become more complex and newer genes emerge e.g. the Hox genes that 
allow body segmentation to take place, which is seen very profoundly in the vertebrates.  Also 
unique to the vertebrate nervous system is the production of myelin, which is produced by 
myelin-related genes that have not been found at this point in time in the invertebrates.  Myelin is 
important as is allows the faster conduction of nerves. 
In collaboration with the Hox gene family, the Pax gene family allows the centralization of the 
nervous system and cephalization- the appearance of a head and brain.  The emergence of 
primordial brains allows more unique interactions and higher degrees of consciousness to 
emerge.  Eventually, during the course of natural selection, the primate brain will emerge and 
subsequentially human consciousness evolves.   
This brings us to our discussion on the three neurogenetic phases of human consciousness.  My 
proposal, in a basic sense, is that when DNA consciousness gives rise to human consciousness 
this process takes place in what I have termed three neurogenetic phases.  I will discuss each 
phase separately and provide many specific NgCC as examples to justify this proposal. 
 
The Three Neurogenetic Phases of Human Consciousness 
I have given a brief description of the interaction-based model of consciousness and how it 
transmogrifies into the concept of ICC.  Additionally, I have explained how the degree of DNA 
consciousness emerges within the trajectory of the ICC and how DNA possesses the ability to 
give rise to higher degrees of consciousness by developing new genes.  I also highlighted the 
importance of the evolution of new genes and how certain genes allow higher degrees of 
consciousness to emerge. 
This brings us face to face with an attempt to understand a genetic account of human 
consciousness.  In this undertaking I have divided this phenomenon into three phases.  I have 
selected a handful of genes to use as examples to illustrate each of the three phases of my 
hypothesis, with the understanding that hundreds of genes may be at work in each of these 
phases, perhaps thousands of genes! 
It is also important to note that some of the genes mentioned in this work have been studied in 
animal models.  However, we must keep in mind that many of these genes are highly conserved 
throughout the animal kingdom and thus a reasonable extrapolation can be made in terms of 
function for the purpose of explaining this hypothesis.  In addition, as of now performing pure 
neurogenetic experiments on humans is not realistic or ethical. 
Phase One: The Emergence of Neuron-based Consciousness 
The DNA molecule gives rise to cellular degree of consciousness.  It does this with a simple but 
yet complicated system of genes being turned on and off by master genes higher in the 
developmental hierarchy.  This is accomplished by gene-gene interactions through a network of 
RNA species, nuclear transcription factors, and epigenetic proteins.  As cells evolved new genes 
appeared via mutations, after which some genes were favored by natural selection and remained 
in the genome.  Novel genes would allow neurons to emerge.  Earlier, synapsins where 
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mentioned as an example and I will point out that there are many more but this is not the focus of 
this article.   
The fact that DNA is primarily responsible for the emergence of neurons is significant as these 
neurons are the primary machinery by which human consciousness functions.  Once neurons 
begin to form and mature they differentiate and compartmentalize into brain regions.  Very small 
changes on the level of the nucleotide can have observable effects at the macroscale level of 
human consciousness.   
The process of forming the brain and the central nervous system requires regulation by master 
genes higher in the developmental hierarchy.  These genes control the transcription of other 
genes downstream, which when activated will style undifferentiated progenitor cells into cells 
with a specific function.  In this case, different types of neurons and ultimately specific brain 
regions.  I will now discuss some genes that execute these functions. 
The Pax3 gene 
The Pax3 gene codes for Pax3 protein, which is a developmental transcriptional factor that is 
expressed during early embryogenesis.13  It is required for neural tube development and closure, 
which is proposed to be regulated by stimulating the ubiquitination and degradation of p53.14  
Ubiquitin is a protein that causes inactivation of other proteins.  Therefore, Pax3 inactivates p53 
by regulated stimulation of ubiquitin. 
 
The p53 is produced by the TP53 gene and controls the rate of cell division.   This is 
accomplished by the involvement of p53 in the G1-phase of the cell cycle, which allows a delay 
between the cell phases. This delay affords time for defects in the DNA molecule to be detected 
and repaired by the DNA damage response pathway before the cell enters into G0-phase.  In the 
G0-phase cell cycle mitosis suppressor proteins activate tissue-specific proteins to be 
synthesized, which is interesting because this is the phase of the cell cycle where the DNA 
molecule expresses what the physical characteristics of the cell will be.  Thus, Pax3 demonstrates 
some control over the cell cycle during neural tube development and closure by its influence 
over p53.   
 
Trans-activation is the process of stimulating a gene or a set of genes.  Pax3 operates as a 
transcriptional regulator that regulates the developmental process in early neurogenesis.  It 
accomplishes this by utilizing sequence-specific DNA binding domains that direct trans-
activation.  Through this mechanism Pax3 acts as a master gene and has been shown to directly 
and indirectly regulate the expression of many genes as downstream targets. For example, Pax3 
regulates Hairy and enhancer of split homolog-1 (Hes1) and Neurogenin-2 (Neurog2) expression 
by acetylation (which is the addition of a –COCH3 group).15  This is important to neurogenesis as 
Hes1 is important for neural stem cell maintenance and Neurog2 plays a role in the specification 
of neuronal subtypes and neurogenesis of both sensory neurons and neural crest cells.   
Another example that demonstrates how Pax3 controls the expression of another gene’s 
influence on the development of brain regions is seen in Meis2 gene regulation.  The Meis2 gene 
codes for Meis2 protein that has been shown to be pivotal in the development of the tectum.16  
The tectum is the dorsal portion of the mesencephalon (midbrain) and is composed of two 
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divisions: the inferior colliculi that serves an auditory function and the superior colliculi that 
serves a visual function.  It has recently been discovered that tectal Meis2 expression levels are 
modulated by Pax3 (and Pax7).17 
It can be visualized with the Pax3 gene example that this gene dynamically effects the formation 
and closure of the neural tube, which is the nascent version of our brain and central nervous 
system.  In addition, by functioning as a master gene high in the developmental hierarchy this 
gene, in essence, orchestrates the formation of neuron subtypes and brain regions that will 
ultimately be used by the human brain to experience consciousness. 
Pax2 and Pax8 genes 
 Early in development, the Pax 2 gene produces Pax2 protein, which is active in neural crest cells 
that give rise to neurons and glial cells of the sensory, sympathetic, and parasympathetic system.  
It has been demonstrated in many studies that Pax2 and Pax8 genes are responsible for the 
overall ear morphogenesis and the continuous neurosensory development.  Specifically, Pax2 is 
required for the proper formation of the organ of Corti development,18 which lies within the 
cochlea of the inner ear.  It has been observed that Pax8 plays a key role in orchestrating the 
dynamic changes in the early gene expression and initial ear morphogenesis.19   
The two genes Pax2 and Pax8 are responsible for the development of the ear.  The ear is 
important as it allows the perception of sound from the external environment, which is 
interaction at a more complex level.  It also allows modalities of communication and increases in 
the degrees of consciousness.  In addition, Pax2 is involved in the activation of neuron subtypes 
that are differentiated from the neural crest cells. 
Pax6 
The Pax6 gene codes for Pax6 protein, which is a developmental transcription factor.  This gene 
and its orthologs are well known master regulators of eye development and are highly conserved 
throughout the animal kingdom.20  Pax6 initiates control over eye development as it mediates the 
ectoderm above the optic vesicles to form the lens of the eye.21  During development Pax6 
controls transcriptional expression of genes that code for transcription factors that are responsible 
for lens formation e.g. musculoponeurtic fibrosarcoma (L-maf), SRY-box containing gene (Sox-
1), prospero homeobox (Prox-1), and lens structural proteins (α-, β-, and γ-crystallins).  
Mutations to the Pax6 gene have been shown to result in ocular dysgenesis and aniridia (the 
absence of an iris).22 
It has also been shown that Pax6 promotes the neurogenic fates (neuronal lineage development 
and migration patterns) of neural progenitor cells, specifically the glial progenitor cells of the 
forebrain.23  The size and cell number of every brain region is controlled by the organization and 
behavior of the neural progenitor cells during embryonic development.  One group of important 
cells is the basal progenitor cells found in the subventricular zone and they give rise to the 
majority of the thalamus and the six-layered mammalian neocortex.  Recent studies on brain 
morphogenesis demonstrate that the proper thalamocortical development is dependent on Pax6 
and neurogenins (Neurog1 and Neurog2).24  Keep in mind that Neurog2 expression is also 
influenced by Pax3 during specifications of neuronal subtypes.  In addition to the corticogenesis 
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of the forebrain and the development of the thalamus, Pax6 has been revealed to participate in 
the regulation of neurogenesis of the Neuron-Glia 2 progenitor cells in the hippocampus.25 
At this juncture it can be seen that Pax6 is involved in development of the eyes, thalamus, some 
of the thalamo-cortical connections, neocortex, and hippocampus.  All of these brain regions are 
vital machinery for human consciousness.  In the same way that the ears are important for the 
perception of sound, the eyes perceive light, the thalamus is important as it serves as a relay 
station that integrates cortical structures throughout the brain, and the hippocampus is important 
as it is required for the long-term potentiation of memory.  But how does Pax6 do all of this?   
In addition to Pax6 control over genes associated with lens formation, Neurog1, and Neurog2, 
Pax6 also accomplishes control over the development of other brain regions on the cellular and 
molecular level with its role in regulating the orientation and mode of cell division during early 
neurogenesis.  One of the mechanisms of control is achieved by the regulation of adhesion and 
apical anchoring of apical progenitors, and the transcriptional regulation of the sperm-associated 
antigen 5 gene (Spag5) expression.26  Spag5 gene codes for the microtubule-associated protein 
Spag5, which is vital to cell division by its direct association with the spindle machinery and the 
regulation of kinetochore microtubule dynamics both of which are vital to cell division and 
migration. 
As we have seen with Pax3 gene, the Pax6 gene also acts as a master gene by regulating the 
expression of other genes- L-maf, Sox-1, Prox-1, Neurog1, Neurog2, and spag5.  I also 
demonstrated the importance of these genes in the differentiation of neural progenitor cells and 
in the development of regions of the brain and nervous system that will eventually be crucial to 
modalities of human consciousness. 
Hox genes: Hoxd4 and Hoxb4 
Hox genes are pivotal key determinants of anteroposterior (AP) patterning of all embryos 
throughout the animal kingdom and are a highly conserved gene family.  During AP patterning 
of the developing hindbrain, which collectively becomes the cerebellum, pons, and medulla, the 
genetic expression borders of many of the transcription factors are aligned at interfaces between 
neural segments.  These interfaces are referred to as rhombomeres, of which there are seven 
segmented lineage-restricted units.  The rhombomeres give rise to some of the ganglia of the 
cranial nerves (CN) e.g. the geniculate ganglion (CN VII) and the petrosal ganglion (CN IX).  
Also keep in mind that the hindbrain plays critical roles in regulating sleep-wakefulness, motor 
coordination, proprioception, and internal sensation. 
The expression of certain Hox genes are involved in the early formation of cranial nerves and the 
maintenance of the rhombomere borders.  For example, Hoxb4 and Hoxd4 genes act as neural 
enhancers that enforce the border of the anterior brain and rhombomeres 6 and 7 in the hind 
brain.  This has been proposed to function on a feedback circuit that aligns the segmental 
expression borders.  The feedback circuit involves Hoxb4, Hoxd4, and retinoic acid receptor β-
gene.27  It has also been suggested that anterior and posterior embryonic compartments are 
distinguished by distinct chromatin states that undergo histone modification at the Hoxd4 
locus.28   
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So here we have a very good example of a few genes- Hoxb4 and Hoxd4 that can have a 
profound effect on the large scale development of the brain and central nervous system; in this 
case the rhombomere borders, and some portions of the cranial nerves.  Another point of interest 
is the Pax6 gene that was discussed previously has been shown to exert control over Hoxd4 gene 
expression.29  
Hox genes: Otx1 and Otx2 genes 
Otx1 and Otx2 gene (vertebrate homologues of the orthodenticle gene) code for the proteins 
Otx1 and Otx2, respectively.  Both have been demonstrated to be required for the proper 
formation of the thalamus, specifically the intervening boundary region known as the zona 
limitans intrathalamica in early neuroembryological development.30  The thalamic complex 
serves as a central relay center for all the information-generating sensory systems.  Therefore, its 
role in consciousness is of vital importance, which was previously pointed out in the Pax6 
section when thalamo-cortical connections were mentioned. 
Otx1 and Otx2 proteins have been shown to be expressed in the human fetal brain during weeks 
7 to 14.31  Otx1 was located predominantly in the proliferative zones of the neocortex and 
hippocampus whereas Otx2 was expressed in the diencephalon, mesencephalon, choroid plexus, 
basal telencephalon, and hippocampal anlage.  In other studies Otx1 was shown to be critical in 
the proper development of the overall cerebral cortex.  For example, mutant Otx1-null mice 
where shown to have developed a cortex 10% smaller than their wild-type litter mates.32 
During development the neural tube regionalizes in an AP and dorsoventral (DV) direction.  It is 
well established that the regional identity, control of growth rate, survival of neuronal precursors, 
and the specification of neuronal fate is controlled along the DV axis by sonic hedgehog gene 
(Shh) and along the AP direction by the fibroblast growth factor-8 gene (Fgf8).  Otx1 and Otx2 
exert dose-dependent antagonism on Fgf8 and Shh expression during the patterning of the 
midbrain.33  Otx2 specifically is essential for the identity, extent, and fate of neuronal progenitor 
domains of the ventral midbrain region, which is the tegmentum. 
Even though only four Hox genes were discussed it can be seen that they play a significant role 
in establishing the early machinery for human consciousness.  At this juncture we have examples 
where Hox genes demonstrate pivotal roles in the maintenance of rhombomere borders, 
formation of divisions of some of the cranial nerves, the development of numerous brain regions, 
and some influence on the total size of the cerebral cortex. 
 Summing up phase one 
As a starting point we have 8 genes (4 Pax genes and 4 Hox genes) that illustrate the first 
neurogenetic phase- the emergence of the brain and the birth of human consciousness.  There are 
perhaps hundreds of more genes and thousands of more interactions that are involved in this 
process that were not mentioned e.g. the Emx2 gene and the TUBB3 gene, just to name a few.  
Note that not just one gene is responsible for brain development or the formation of a specific 
brain region.  Rather it is the interactions of multiple genes that must cooperate in a coordinated 
fashion.   Examples of this are seen with the genes that give rise to the thalamus and midbrain.  
These genetic examples also demonstrate how DNA gives rise to human consciousness.  This 
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coordinated effort implicates that a degree of consciousness is at work as this process also 
requires the action of master genes that command and communicate with other genes.  
Consequently, this collectively justifies that the first neurogenetic phase is not a random act that 
evolved surreptitiously.  There is a degree of consciousness behind this- DNA consciousness. 
Phase Two: The Continuum of Neuron-based Consciousness 
Before I discuss some of the neurogenetic correlates of human consciousness involved in the 
second phase I first want to clarify what I mean by the continuum of neuron-based 
consciousness.  I will begin by briefly discussing a current model that relies on neuron-neuron 
connections to explain the process of human consciousness. 
In the article Biology of Consciousness by Gerald Edelman et al. (as well as many other works 
by Edelman), a strong case was made to support that consciousness (at least in vertebrates) is a 
dynamic, integrated, and multimodal mental process which is entailed by physical events in the 
forebrain.34  Consciousness, in this proposal, is primarily supported by the infrastructure of 
cortical-cortical, cortical-thalamic, and thalamo-cortical neuron connections.  These connections 
provide a structural basis, in a neurological sense, for the dynamic reentry of signals between 
regions of the brain.  Specifically between different parts of the cortex and between the cortex 
and the thalamus, all of which are reciprocal.  The neural activity between the thalamus and the 
cortex (reciprocally) constitutes what is referred to as the dynamic core hypothesis.   
This proposal gives a great deal of understanding, at least conceptually, as to what the brain does 
during the process of human consciousness.  According to this proposal the dynamic core 
provides a sequence of integrated discriminations which produces unitary conscious scenes that 
establish the phenomenal experience of consciousness.  This ongoing process is what I 
collectively refer to as the continuum of neuron-based consciousness.  I make this distinction 
because if human consciousness is to be viewed as a process that functions on neuron activity 
producing a continuous stream of stimuli-generated scenes then the phrase continuum of neuron-
based consciousness seems appropriate.   
What is the main difference between the dynamic core hypothesis and the continuum of neuron-
based consciousness?  The distinction is that the continuum of neuron-based consciousness 
follows the format established in the concept of the ICC, which allows some partition from the 
other degrees of consciousness e.g. cellular or atomistic.  Secondly, I do not maintain that only 
neurons and the brain are responsible for human consciousness.  My proposal maintains that 
there are neurogenetic correlates involved in the continuum of neuron-based consciousness. 
In this section I am attempting to get beneath the neurological machinery in an attempt to 
understand what happens in a neurogenetic sense during the continuum of neuron-based 
consciousness.  The DNA in the genome of the neurons continues to function during the ongoing 
process of human consciousness throughout the lifespan.  If there are abnormalities in the 
functioning of DNA e.g. mutations, deletions, or single nucleotide polymorphisms (SNP) then 
disturbances or decreases in the degree of human consciousness can be observed clinically. Once 
again, small changes on the level of the nucleotide can have observable effects at the macroscale 
level of human consciousness.  In the first part of this section I use psychiatric disorders to 
illustrate this point. 
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An additional quality that is important to the continuum of neuron-based consciousness is the 
process of neuron plasticity.  In the second part of this section I will discuss some genes that are 
involved in this process.  Keep in mind some of the genes that I will discuss in this section are 
also involved in neurodevelopment and therefore can be placed in the first or second 
neurogenetic phase depending on when they are being expressed.   
PTCHD1 locus disruptions- association with Autism 
Autism is characterized by impairments in communication and socialization; specifically 
reciprocal interaction, and the presence of restrictive and repetitive behaviors.  In terms of 
consciousness there is impairment in interaction and the autistic person appears to be more 
introverted.  This signifies a difference in degree of human consciousness- not good or bad but 
merely an observable divergence in degree.  
The PTCHD1 gene is located on the X-chromosome and it produces the patch-related 
transmembrane protein 1 (PTCHD1).  PTCHD1 and other transmembrane signaling proteins 
(neuroexins and neuroligins) function to strengthen the synapses of the neurons.  Disruptions in 
regions of this gene have been strongly associated with autism spectrum disorders and 
intellectual disability.35   
A more recent study on a family with two boys with a PTCHD1 gene abnormality demonstrated 
intellectual disability with and without autism in each of these boys.36  Therefore other genes 
besides PTCHD1 are likely to be involved in autism and other variations of this disorder.  At this 
point much is being discovered about the neurogenetics of autism.  More candidate genes are 
likely to emerge, but for the purpose of illustrating NgCC in the second neurogenetic phase 
PTCHD1 serves as a good example as it does demonstrate an association with Autism.   
Schizophrenia-associated genes 
Schizophrenia (SZ) is characterized by profound emotional and cognitive disturbances.  These 
symptoms are also associated with defects in cortical activity and hallucinations.  In terms of 
consciousness SZ represents a disorder of thought and volition in where there are alterations in 
the degree of human consciousness.   
Several gene abnormalities have been associated with SZ etiology.  Hypothetically this has 
suggested that epistatic interactions between multiple susceptibility genes converge into a 
network resulting in SZ pathology.  This will eventually function to illustrate that the 
coordinated orchestration of genes and genetic products are required in order for the continuum 
of neuron-based consciousness to provide the infrastructure of human consciousness.  I will now 
discuss a few examples of genes that are involved in SZ. 
 PDE4B gene 
The PDE4B gene belongs to a family of genes (PDE4A-D) and produces phosphodiesterase 4B 
protein.  PDE4B has been characterized as being able to hydrolyze cAMP and to turn off cAMP 
signaling cascades.  These cAMP are very important for intercellular communication.  PDE4B 
also plays an important role in synaptic plasticity that is involved in learning and memory.  
PDE4B polymorphisms (a variation in a gene too common to have recently occurred by a new 
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mutation) have been strongly associated with SZ, which was demonstrated in a recent cohort 
study involving 428 cases.37  However, many diagnosed schizophrenics do not carry the PDE4B 
polymorphism.  Therefore PDE4B polymorphism is only associated with a portion of SZ 
patients. 
 DISC1 gene 
Disrupted in Schizophrenia 1 (DISC1) gene produces DISC1 protein.  This protein interacts with 
multiple proteins at different locations and developmental periods.  DISC1 has effects on 
neuronal development and neuron signaling.  It is also part of the microtubule organizing center 
(the centrosome) and is involved in the cytoskeletal process in neuronal migration.38  DISC1 
activity in the centrosome is similar to the function rendered by Spag5 gene that is controlled by 
the Pax6 master gene mentioned in the first neurogenetic phase. 
DISC1 and PDE4B proteins interact to form the DISC1-PDE4B complex.  The abnormal 
functioning of this complex has been implicated in many of the molecular mechanisms 
underlying SZ and other mental illnesses.39  This illustrates not only the individual contributions 
that DISC1 and PDE4B make to SZ, but also the importance of their interactions in the proper 
formation of the DISC1-PDE4B complex.  A genetic abnormality in either the DISC1 or PDE4B 
gene results in the improper functioning of the DISC1-PDE4B complex which has a strong 
association with SZ. 
 ZNF804a transcription factor 
ZNF804a is a transcription factor that regulates the expression of four SZ-associated genes- 
PRSS16, COMT, PDE4B, and DRD2.  Consequently, it has been proposed that ZNF804a 
expression is a possible candidate mechanism that confirms SZ risk.40  This is significant 
because it demonstrates that one gene can produce a transcription factor that in turn can have 
downstream effects on multiple genes which results in an alteration in the degree of human 
consciousness seen in SZ.  This alteration in consciousness can be observed and quantified 
clinically. 
In the first part of this section the use of an autism-associated gene (PTCHD1 locus disruptions) 
and several SZ-associated genes demonstrate the importance of genetic interactions that underlay 
the continuum of neuron-based consciousness.  This is seen with PDE4B and its interactions 
with DISC1.  It is also seen with ZNF804a and its control over the expression of PDE4B (and the 
other three genes listed).  Interactions such as these are important to human consciousness, which 
relies on the proper functioning of the genetic biology underlying the neuron.   
Neuron plasticity 
Earlier in this article I briefly discussed a family of genes called synapsins, which are involved in 
neuron plasticity and contribute to making a neuron a neuron.  During the discussion of PDE4B 
it was mentioned that one of its many functions was the involvement in neuron plasticity.  
Neuron plasticity is defined as the ability of the neuron to reorganize and form new connections 
throughout life.  Human consciousness requires that the neurons in the brain change and form 
new connections in response to new information or stimuli.  Consequently, the process of neuron 
plasticity is crucial to the continuum of neuron-based consciousness.  In addition, neuron 
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plasticity would also be required in the dynamic core model mentioned at the beginning of this 
section, which would imply that these genes are important to that model as well.   
The proper genetic expression of certain genes is vital to neuron plasticity.  Hence they are 
equally important to human consciousness.  Next I will discuss three specific genes that are 
involved in neuron plasticity and discuss their importance to the second neurogenetic phase. 
Brain-derived Neurotrophic Factor (BDNF) gene 
BDNF gene is located on chromosome 11 and produces BDNF which is called a neurotrophic 
factor because it was discover in the early 1980’s that it promoted the survival of a subpopulation 
of neurons.41  A multitude of stimuli e.g. light, osmotic stimulation, and electrical stimulation 
have been shown to increase BDNF expression (measured by mRNA production) in several 
brain regions- the visual cortex, hypothalamus, and hippocampus, respectively.  The BDNF gene 
is involved in the maturation of the prefrontal cortex and the hippocampus, as well as being 
involved in learning and memory.42  A genetic defect (polymorphism of val66met) in the BDNF 
gene has been shown to impair memory and hippocampal function by decreasing the modulation 
of hippocampal plasticity.43  Therefore, neuron plasticity in the hippocampus is an important 
process underlying memory and can be adversely affected by mutations in the BDNF gene. 
A different study also supports that BDNF is a potent modulator of plasticity in the synapse of 
the neuron.44  In this study the important association of another brain structure, the amygdala, in 
addition to the hippocampus is highlighted.  The hippocampal-amygdala circuitry is modulated 
by BDNF-induced changes in synaptic plasticity in response to emotional memory.  Other roles 
of neuron plasticity and connectivity in the amygdala will be discussed in the section on the 
∆FosB transcription factor.  
Fibroblast Growth Factor-2 (FGF-2) gene 
FGF-2 gene produces FGF-2 which is known to promote the proliferation of neuroprogenitor 
cells and also has been demonstrated to be generated in the hippocampus after brain injury.45  
FGF-2 has established key functions in neurogenesis, promotion of axonal growth, neuron 
differentiation during development, and in the maintenance of neuron plasticity during 
adulthood.46  In addition, FGF-2 has been shown to have important roles in synapse plasticity 
associated with learning and memory. 
BDNF and FGF-2 have very similar functions as far as their involvement in neuron plasticity 
during memory and learning.  Interestingly, both of these factors have been shown to have an 
association in depression.  BDNF demonstrates reduced expression in the hippocampus and the 
prefrontal cortex in subjects with depression, which is further associated with the induction of 
dendritic atrophy in these regions.47  FGF-2 expression is also reduced in depression which was 
seen by decreased FGF-2 mRNA levels in the frontal cortex and regions of the hippocampus.48 
Both genes BDNF and FGF-2 are underactive in the frontal cortex and hippocampus in 
depression.  Depressive disorders are significant to the understanding of human consciousness as 
they represent deficits in emotional processing, bias toward negative stimuli, and decreased 
motivation.  These clinical symptoms are reflections of the underlying morphological changes in 
the brain that are the end result of decreased neuron plasticity.  Therefore underactive BDNF and 
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FGF-2 genes result in decreases in neuron plasticity, consequent neuron atrophy, and decreases 
in connectivity in the frontal cortex and hippocampus.  The dysfunction of neurons in these brain 
regions are correlated with associated objective symptoms e.g. decrease in memory 
(hippocampus) and decrease in concentration (frontal cortex) in depressed patients.  All of this 
represents a decrease in the degree of human consciousness that is connected to genes that are 
involved in neuron plasticity.  Keep in mind that many other factors are proposed to be involved 
in depression e.g. low serotonin in the brain. 
 ∆FosB transcription factor 
∆FosB is a transcription factor produced by the FosB gene.  This transcription factor has been 
shown to affect the expression of four other genes.  It induces (as a trans-activator) the GluR 
gene, the Cdk5 gene, and the NFκB gene; whereas it represses the dynorphin gene expression.49  
This is important as these four genes have the following functions: 
• GluR- decreases the glutamatergic response to AMPA-GluR 
• Cdk5- decreases the regulation of dopamine and glutamate 
• NFκB- decreases the dendritic spines produced on the medium spiny neurons 
• Dynorphin- decreases the inhibition of dopamine release 
Interestingly, many drugs of abuse increase the production of ∆FosB in the brain.  ∆FosB then 
demonstrates a sustained expression and continues to have a prolonged effect on the four genes 
listed above.  These four genes in turn have negative biological effects on neurons in the brain.  
These effects consist mainly of decreases in neuron plasticity that results in gross brain loss and 
decreased connectivity that can be seen on imaging studies.  An example of this was 
demonstrated in the Prescription Opioid Addiction Treatment Study (POATS), in where imaging 
studies on patients who underwent long-term prescription opioid use demonstrated bilateral loss 
of the amygdala and a decrease in connectivity in three of the amygdala white matter tracts- the 
stria terminalis, ventral amygdalofugal, and uncinate fasciculus.50  These white matter tracts 
connect the amygdala to the brainstem, nucleus accumbens, and prefrontal cortex respectively. 
These ∆FosB drug-induced changes in the brain produce a behavioral phenotype that promotes 
addictive behavior.  In the case of the amygdala, this region of the brain is involved in pain 
perception and rating the emotional response to the environment.  Decrease of gross mass in the 
amygdala and decreases in its connectivity to other brain regions can be correlated to specific 
clinical symptoms e.g. hyperalgesia and hyperkatifeia.51   
Hyperalgesia is defined as a clinical symptom in where there is an increased sensitivity to pain 
that is not proportionate to the injury; and in the case of opioid-induced hyperalgesia the opioids 
actually cause the patient to experience more pain due to the long-term use of opioids.  In 
hyperkatifeia opioid use causes the patient to experience a hypersensitivity to negative emotional 
states as well as increased intensity of emotional distress.  As mentioned above the use of opioids 
increases ∆FosB expression which has downstream effects on the amygdala, which is one of the 
brain regions involved in pain perception and rating emotional response.  So here we have an 
example where a drug has an effect on a gene which in turn has a negative effect the brain’s 
perception of external events e.g. pain perception and emotional response to the external 
environment. 
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The amygdala has been mentioned a few times in this section and so has depression.  
Interestingly, a recent comprehensive review of imaging studies has demonstrated decreases in 
connectivity between the amygdala and the insular cortex in patients with major depressive 
disorder.52  The amygdala-insular cortex connection is important in the formation of emotional 
memory.   
A possible neurogenetic correlate has been associated with this connection between the 
amygdala and the insular cortex.  A functional deletion variant of the ADRA2B gene, which 
encodes for α2b-adrenergic receptor, has been associated with an increase in functional 
connectivity between the amygdala and the insular cortex.53  No current studies have confirmed 
any gene abnormalities with decreases in connectivity between these two brain regions.  Of 
course at this point more research is needed in order to associate clinical symptoms and changes 
in the brain to the underlying neurogenetic correlates.  However, it does highlight the importance 
of the connections of the amygdala to the other regions of the brain. 
 Summing up phase two 
To illustrate some of the NgCC in the second neurogenetic phase of human consciousness 
genetic factors involved in psychiatric disorders and neuron plasticity were utilized.  It was 
demonstrated that genetic abnormalities in PTCHD1, PDE4B, DISC1, and ZNF804e can result 
in alterations in the degree of human consciousness, which was observed in the psychiatric 
disorders discussed in this section. 
Genetic factors were shown to have an effect on neuron plasticity which affects neuron 
connectivity.  The plasticity and connectivity of the neurons and the correct functioning of the 
underlying neurogenetic correlates are necessary for the proper functioning of the neuron-based 
continuum which is vital for the degree of human consciousness.  It was demonstrated that 
∆FosB induction results in prolonged addictive behaviors and eventual brain loss in the 
amygdala, which has been correlated with clinical symptoms.  This was also seen with the 
decreased expression of BDNF and FGF-2 in the frontal cortex and the hippocampus which were 
correlated with symptoms of depression.   
It has been clearly demonstrated that genetic abnormalities have a direct relationship to degrees 
of human consciousness by their unswerving effect on the infrastructure i.e. the continuum of 
neuron-based consciousness.  Malfunction of the genes result in the improper functioning of the 
neurons which ultimately produces objective clinical symptoms that can be utilized to represent 
an alteration in the degree of human consciousness.   Finally, in the second neurogenetic phase I 
have provided evidence that the continuum of neuron-based consciousness involves both NCC 
and NgCC.  This differs from many current models of human consciousness that gravitate solely 
on NCC.  In my model the continuum of neuron-based consciousness, which is the crux of the 
second neurogenetic phase of human consciousness, the importance of NCC is recognized, but 
NgCC are acknowledged as being equally, if not more, important.   
Phase Three: Neurodegeneration 
Neurodegeneration is an age-related process of deterioration of the brain and nervous system.  
This process has observable symptoms that are noted on the spectrum of human consciousness 
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e.g. decreases in awareness, abnormal thoughts, memory impairments, and difficulty 
concentrating.  However, neurodegeneration can be accelerated in diseases like Alzheimer 
Disease (AD) which has a genetic component.  I will use AD as a prime example for the third 
neurogenetic phase.  Before I do this allow me to give a brief description of AD. 
AD slowly erodes some of the modalities of consciousness.  Memory loss is the primary 
symptom in AD and when this deteriorates the patient’s sense of past, present, and future 
gradually becomes downgraded.  The AD patient also begins to loss the ability to place names 
with faces (prosopagnosia) and the ability to identify objects (anomia).  Cognitive functions are 
also affected, which makes processes like performing calculations difficult.  The AD patient can 
also become disorientated and unable to associate ideas with events or words.  In addition, 
behavioral abnormalities can occur in AD e.g. screaming and inappropriate mannerisms.  
Essentially, with all of these symptoms the person ceases to be the person that they once were.  
This is to say that their degree of consciousness has been reduced secondary to the AD 
pathology. 
There are two main pathological features of AD.  The first is the abnormal accumulation of beta-
amyloid (Aβ) that forms senile plaques and the second is the formation of neurofibrillary tangles 
(NFTs) that consist of hyperphosphorylated tau.  I will not go into detail in regards to the 
pathophysiology of AD as this has been done in other publications.54  However I will discuss Aβ 
accumulation as some of the gene mutations that I will discuss next in this section are correlated 
with AD due to Aβ accumulation. 
It is now understood that Aβ begins to accumulate decades before signs and symptoms of AD are 
manifested.  Consequently, a new model and a new view of AD have been established in where 
three clinical phases have been formulated according to the 2011 AD diagnostic guidelines.  
These guidelines have been reviewed in previous works. 55   The three phases are an 
asymptomatic preclinical phase, a symptomatic predementia phase, and dementia phase.  I will 
now discuss five AD genes. 
 The Amyloid Precursor Protein (APP) gene 
The APP gene produces the APP protein which is an integral membrane protein in the neuron 
that is concentrated in the synapse, regulates synapse formation, neural plasticity, and iron 
export.  Proteolysis of APP is performed by another protein complex called γ-secretase. This 
process generates Aβ 39-42. There is a large amount of evidence that indicates that some cases 
of AD are caused by mutations in the APP gene.  In earlier studies it was found that a point 
mutation in the APP gene on chromosome 2156 and double mutations in exon 1657 were 
pathogenic mutations associated with AD.   Currently there are many more mutations of the APP 
gene that are under investigation for this gene’s correlation to AD. 
The PSEN1 and PSEN2 genes 
Presenilin-1 (PSEN1) and Presenilin-2 (PSEN2) genes produce the proteins PSEN1 and PSEN2 
respectively.  These two proteins, along with nicastrin and APH-1, form a protein complex 
known as γ-secretase.  The γ-secretase cleaves the APP while it is still in the neuron membrane.  
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Therefore the normal functioning of γ-secretase is required in order for this process of cleavage 
to work.   
Mutations in PSEN1 and PSEN2 have been strongly correlated with AD.58  It is proposed that 
when there are mutations in the PSEN1 and/or PSEN2 genes that the γ-secretase complex formed 
is abnormal.  Consequently, the ability of the γ-secretase complex to cleave the APP is impaired.  
This improper cleavage of APP is proposed to be another factor that contributes to abnormal Aβ 
accumulation.   
In the second neurogenetic phase we saw the importance of protein complex DISC1-PDE4B and 
its relationship to SZ.  Here we see something similar with γ-secretase and its relationship to AD.  
In both protein complexes the proper genetic expression of all the proteins involved are 
important to the overall function of that complex.  A genetic mutation in even one of the 
protein’s genes can result in pathology that has a negative effect on human consciousness e.g. SZ 
and AD. 
APOE-ε4 phenotype 
Apolipoprotein-ε4 gene variant (APOE-ε4) produces the APOE-ε4 protein.  This protein can 
influence brain structure and function by affecting synaptic generation and other restorative 
mechanisms involving cholesterol transport and metabolism. Carriers of the APOE-ε4 allele 
show an increased risk for developing AD in a gene dose dependent manner.59  The APOE-ε4 
allele is present in about 60% of AD patients and this allele’s presence reduces the median age of 
onset to 68 as opposed to 84 in non-carriers.60  
A recent study demonstrated that APOE-ε4 directly damages the blood vessels of the blood brain 
barriers and this neurovascular damage decreases Aβ clearance.61  This is interesting as this 
vascular damage has a secondary effect on the neurons that in turn contribute to AD pathology. 
TREM2 gene 
The triggering receptor expressed on myeloid cells-2 (TREM2) gene produces the TREM2 
protein.  TREM2 functions to regulate phagocytosis, suppress inflammatory reactivity, and 
repress cytokine production and secretion in the microglia cells in the brain.  Two recent studies 
verified that a rare missense mutation that results in an abnormal TREM2 variant is associated 
with a significant increase in late-onset AD.62,63 
At this juncture I have discussed five genes that are associated with AD.  These gene mutations 
result in an abnormal protein product that has a negative effect on the neurons and the brain that 
ultimately result in the AD pathology.  However, I would like to briefly discuss a gene therapy 
that may reverse the loss of memory seen in AD.  This will further illustrate the connection 
between the neurogenetics in the third phase and human consciousness. 
FGF-2 gene therapy 
FGF-2 was discussed in the section on neuron plasticity.  It was also discussed that FGF-2 (and 
BDNF) expression was decreased in depression.  FGF-2 is an established neurogenic factor of 
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proliferation and differentiation for multipotent neural progenitors.  In 2011, a study involving 
the injection of active FGF-2 gene into AD-mice resulted in improvement in memory.64 
 
Even though this was only tested in transgenic mice the significance of the reversal of AD-
associated memory loss should not be underrated.  If we look at the mouse’s degree of neuron-
based consciousness and the fact that it’s degree of consciousness was decreased secondary to 
AD pathology and then increased with FGF-2 gene therapy this would suggest that neuron-based 
consciousness can be manipulated or modified with gene therapy. 
 
 Summing up phase three 
The process of neuron degeneration results in decreases in the degree of human consciousness.  
Neuron degeneration has this effect on human consciousness as it erodes the global modalities 
associated with its proper functioning.  In previous works I have discussed the connection 
between AD and DNA consciousness.65  Here I have discussed five AD genes- APP, PSEN1, 
PSEN2, APOE-ε4, and TREM2.  These genes have all been associated with a significant 
increase in the risk of AD.  
By using AD genes as an example, I have demonstrated that genes have a direct effect on 
decreasing modalities of human consciousness later in life.  Some of these gene abnormalities 
result in Aβ accumulation, but it takes decades of gradual accumulation before enough damage 
has been done to the neurons and brain before objective symptoms manifest.  Other gene 
abnormalities which were demonstrated with the examples of APOE-ε4 and TREM2, have 
adverse effects on other processes e.g. circulation and inflammation, respectively.  However, 
these types of gene abnormalities have a long-term secondary effect on the neurons and the brain 
that contribute to AD.   
Collectively this section verifies the third neurogenetic phase of human consciousness as it was 
demonstrated that genes can affect, in this case decrease, degrees of human consciousness.  
Genetic therapies e.g. the FGF-2 genetic therapy make it obvious that this process of neuron 
degeneration may be reversible.  In addition, ongoing research with stem cells may yield similar 
results. 
Discussion 
When looking at the first neurogenetic phase of human consciousness initially, embryonic 
development requires the production of undifferentiated cells and subsequentially those cells 
must mature into cells with a specific function.  The maturation of a cell with a differentiated 
phenotype requires stringent control of gene expression, which must be regulated in both space 
and time throughout this process.  This requires the active regulation of developmental control 
genes which are also called master genes that influence the activity of other genes. This is 
accomplished by transcriptional regulation.  It has been demonstrated in this article that 
neurogenetic developmental genes that act as master genes e.g. Pax3 and Pax6 exert their control 
by turning on and off other genes.  Consequently, Pax3 and Pax6 both have critical roles in brain 
morphogenesis and give rise to the large scale structures that allow the human brain to interact 
with and interpret the environment. 
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Later, the developing neural tube is subdivided by regionalization events that are distinguished 
by the genetic expression of specific combinations of transcriptional regulators.  The anterior 
ectoderm will regionalize into the forebrain, midbrain, and hindbrain.  This ultimately gives rise 
to molecularly defined regions that will subsequently differentiate into anatomically and 
functionally specific regions of the human brain with a distinct AP and DV character.   
When observing what is known at this point of neurogenetic development are we to accept that 
this is all a series of random acts committed by genes or is there a degree of consciousness at 
work here orchestrating the final outcome?  If we look at just the small sample of genes that were 
provided as an example in the first neurogenetic phase and then add to this the total number of 
potential genes that are involved we simply cannot accept that is a serendipitous process that 
randomly fell together by trial and error.  Hence we must change our way of viewing DNA.  We 
must entertain the concept that there is a clandestine degree of consciousness at work here that 
has been undetectable up until 50 or 60 years ago. 
In the second neurogenetic phase we saw the importance of gene-gene interactions and the 
control of genetic expression.  Genetic abnormalities can produce psychiatric disorders like 
autism and SZ.  These psychiatric disorders demonstrate a variance in the degree of human 
consciousness where reality is not only perceived in a different manner but effects on cognition 
are also evident.  This phenomenon demonstrates how a very small change at the level of the 
nucleotide can manifest objective changes seen on the macroscopic scale of human 
consciousness. 
While the brain functions the neurons change morphologically by making new connections to 
other neurons and losing connections to others.  The phenomenon of neuron plasticity allows the 
neurons to provide an infrastructure for the continuum of human consciousness, which connects 
all of the individual series of stimuli into a collective whole.  The under-expression of genes e.g. 
BDNF and FGF-2 inhibit the neurons ability to provide the continuum by decreasing neuron 
plasticity.  This results in decreases in the degree of human consciousness that is seen in mood 
disorders like depression, which can have a profound effect on cognitive modalities and memory 
that are related to human consciousness.  In depression the end results of neuron plasticity on the 
brain can be confirmed objectively on imaging studies.   
In the second neurogenetic phase it was also seen that certain transcription factors that act as 
trans-activators can have an effect on multiple genes.  This was demonstrated with ZNF804e 
transcriptions factor’s effect on SZ-associated genes and ΔFosB transcription factor’s effect on 
genes associated with neuroplastic changes in the brain involved in addiction. 
The results discussed in the second neurogenetic phase shows that NgCC underlay the correct 
functioning of the continuum of neuron-based consciousness.  Abnormalities in the function of 
any NgCC can result in psychiatric disorders and/or decreases in neuron plasticity, which both 
have objective effects on human consciousness. 
The third neurogenetic phase demonstrates the genetic influence on neurodegeneration.  The 
significance of neuron degeneration is that it represents an erosion of human consciousness.  AD 
was used as a primary example, but other genes have been associated with other forms of 
dementia as well.  Mild cognitive impairment is considered the result of normal aging but 
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essentially there is a decrease in normal gene expression which is involved in the maintenance of 
neurons that are responsible for the resulting symptomatology.  The expression of many genes is 
affected in an age-dependent fashion, but specific mutations have been associated with an 
increase in earlier onset and severity of impairment as seen in AD. 
The end result of neuron degeneration demonstrates decreases in the degree of human 
consciousness which is seen objectively in diseases like AD.  Essentially, in the third 
neurogenetic phase the degree of human consciousness is gradually decreased over time.  
However, with the promise of new genetic therapies the process of neuron degeneration may be 
able to be reversed.  The concept of reversing neuron degeneration with gene therapy is 
interesting because it suggests that the third neurogenetic phase may not be a one-way street. 
 
Conclusion 
The neurogenetics of consciousness is the study of the genetic processes in where the degree of 
DNA consciousness gives rise to the emergence of neuron-based degrees of consciousness.  It is 
an initial identification and enumeration of the NgCC. 
I have summarized that after the emergence of the machinery used for neuron-based 
consciousness that this genetic process then provides a continuum of human consciousness.  
Unfortunately, toward the end of life neurodegeneration takes place.  This happens at an age-
related pace, but some gene mutations are associated with an acceleration and earlier onset of 
this process.  Every gene discussed in each of the three neurogenetic phases in this article 
represents, at least to some degree, a NgCC underlying the NCC. 
This article provides evidence that genes have a tangible effect on human consciousness.  This is 
demonstrated in three obvious neurogenetic phases.  This should not be too hard to accept as for 
some time now we have readily accepted the role of genes in tangible attributes e.g. behavior and 
intelligence.  As scientists learn more about the human genome and the downstream effects that 
can be observed on the phenotypic expression a more complete picture will begin to crystallize. 
The small amount of evidence accumulated in this article justifies the second hypothesis that was 
purposed in the theory of DNA consciousness, which is that DNA gives rise to higher degrees of 
consciousness e.g. human consciousness.  The first premise of the theory of DNA consciousness 
is that DNA possesses a degree of consciousness.  This is justified in that the emergence and 
maintenance required during the development and continuum of human consciousness is not a 
random process that serendipitously evolved.  It is an orchestrated process that requires a degree 
of consciousness even if this is a degree of consciousness that we cannot see.   
At this point in time the difficulty of discovering a testable model is a significant problem for 
both proposals put forth by the theory of DNA consciousness.  First, how to test whether or not 
DNA possesses what we would accept as a degree of consciousness?  Second, is it ethical to run 
neurogenetic experiments on the human brain?  Therefore, this author is left solely with the 
process of extrapolation in order to attempt to establish a core of this nascent model of human 
consciousness.  Perhaps this will someday lead to more objective methods. 
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In the future, when genetic therapies become more reliable, enhancements on some of the 
modalities of human consciousness may be obtainable.  The possibility of a selected genetic 
destination made available by human enhancements was proposed in previous works.66  Some 
may consider this unrealistic or even science fiction.  However, with new neurogenetic therapies 
underway, as seen with FGF-2 therapy in AD, it is not a far stretch to think of using this same 
type of therapy in a non-AD patient for the sake of enhancing degrees of human consciousness.  
In this way DNA consciousness could continue to give rise to higher degrees of consciousness 
beyond that of human consciousness.   
As far as this article is concerned I have just scratched the surface in terms of the three 
neurogenetic phases of human consciousness and it is not close to being complete.  It is the 
initiation of a much larger and long-term project.  At this juncture this is the information that I 
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